Furthermore, the stable transfection of a cyclin D1 antisense construct into human pancreatic cancer cells leads to decreased levels of the mRNA of chemoresistance genes such as MDR1 and MRP [37]. The gene discussed is CCND1; the disease is pancreatic neoplasm.